Plain-English translation of NCT07804849 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Type 1 Diabetes Mellitus research guide โPhase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether verapamil, a medication that has been safely used for heart and blood pressure problems for many years, can help protect the insulin-producing cells in your pancreas when you have just been diagnosed with type 1 diabetes. Researchers believe this medication might slow down the body's attack on these cells, which could help preserve your body's natural ability to make insulin. Half of participants will receive the medication, and half will receive a placebo (a pill with no active ingredient).
When type 1 diabetes develops, the immune system mistakenly attacks and destroys the cells in the pancreas that make insulin. Recent research suggests this medication might be able to protect these cells from being destroyed during this early, critical window right after diagnosis. If successful, this treatment could help children and teenagers need less insulin and maintain better blood sugar control.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will come to the clinic for study visits where you'll take either verapamil or a placebo pill once daily, along with your regular insulin therapy. The research team will monitor your blood sugar levels, measure your pancreatic cell function, and check how much insulin you need over time. You'll have blood tests and follow-up visits to make sure the medication is safe and to see if it's helping protect your insulin-producing cells.
AI-generated summary from trial data ยท Sep 17, 2026 ยท Not medical advice
Egypt